Catch up on the latest research findings and success stories from across the department.
20 September 2017
The Diabetes Trials Unit have published the results of two mega-trials, involving over 20,000 participants and 36 countries, shedding new light of the impact of diabetes drugs on the cardiovascular system.
14 September 2017
We are pleased to anounce that we have three new University Research Lecturers within RDM.
12 July 2017
An Oxfordshire man who took part in fatty liver disease research after the condition was discovered through his role in an Ebola vaccine trial has urged others to participate in NHS research.
4 April 2017
An exciting new chapter in NHS medical research in Oxford began at the start of April, with the £113.7m renewal of the NIHR Oxford Biomedical Research Centre (BRC).
30 January 2017
International research company Novo Nordisk is investing £115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University.
28 September 2016
New research finds genetic differences that help to explain why some babies are born bigger or smaller than others. The research, led by the University of Oxford, also reveals how genetic differences provide an important link between an individual’s early growth and their chances of developing conditions such as type 2 diabetes or heart disease in later life.
23 August 2016
Well done to Dr Constantinos Christodoulides in OCDEM who has been awarded a BHF Intermediate Clinical Research Fellowship.
23 August 2016
Nicknamed ‘Why?’ during his years as a student nurse, Tony O’Malley is always asking questions. His quest for explanations is a trait that’s come in handy time and time again in his role as a patient advocate. ony recently won the 2015 Supporter of the Year Gold Award in the Oxford University Hospitals NHS Foundation Trust, Annual Staff Recognition Awards, a testament to his tireless campaigning to improve patient safety and patient engagement in diabetes care. I caught up with him to learn more about what got him involved in patient advocacy and how we can all work together to improve clinical care.
Precision medicine study reveals how our genetics can alter action of metformin, the most commonly used Type 2 diabetes drug
17 August 2016
RDM researchers have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may vary between individuals.